GAIN THERAPEUTICS INC shareholders Q3 2023

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.41 and the average weighting 0.0%.

GAIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CM Management, LLC 90,000$295,2000.31%
Greenlight Capital 588,410$1,929,9850.11%
PRELUDE CAPITAL MANAGEMENT, LLC 58,100$190,5680.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,100$148,9030.00%
Householder Group Estate & Retirement Specialist, LLC 2,500$8,2000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HM PAYSON & CO 1,000$3,2800.00%
GROUP ONE TRADING, L.P. 1,937$6,2570.00%
GEODE CAPITAL MANAGEMENT, LLC 151,476$489,3550.00%
MORGAN STANLEY 1,300$4,2640.00%
BlackRock Inc. 27,925$91,5940.00%
Citadel Advisors 1,700$5,4910.00%
Citadel Advisors 4,100$13,2430.00%
Citadel Advisors 45,876$148,1790.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 65,226$210,6800.00%
SIMPLEX TRADING, LLC 8,650$280.00%
Tower Research Capital LLC (TRC) 2,870$9,4140.00%
Renaissance Technologies 46,900$1540.00%
ROYAL BANK OF CANADA 210,000$689,0000.00%
VANGUARD GROUP INC 70,280$230,5180.00%
External links

This page lists GAIN THERAPEUTICS INC's shareholders in Q3 2023. To view GAIN THERAPEUTICS INC's shareholder history, click here.